Received: 15 October 2021
Accepted: 13 May 2022
First Online: 1 July 2022
: Authorization of the patient to voluntarily participate was obtained throughout the application of informed consent and expected benefits were explained to each patient. Applied protocols were approved by Institutional Ethical Committee at IPK (CEI-IPK-8918). The handling of all the data of each patient, the clinical-epidemiological record and the results, were carried out under the strictest standards of confidentiality.
: Consent for the scientific/academic use of samples and data was obtained from the patients.
: The authors declare that they have no competing interests.